Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Vijayveer Bonthapally"'
Autor:
Margaret Hux, Denise Zou, Esprit Ma, Peter Sajosi, Andreas Engstrom, Ross Selby, Eugene Benson, Andrew Briggs, Vijayveer Bonthapally
Publikováno v:
Journal of Health Economics and Outcomes Research
**Objective:** To evaluate the cost-effectiveness of brentuximab vedotin in patients with R/R sALCL from a UK NHS perspective. **Methods:** A partitioned survival model used clinical outcomes for brentuximab vedotin from the pivotal phase-2 single-a
Externí odkaz:
https://doaj.org/article/7d27a3d6afc843208c70026aeb5511d8
Effect of Zuranolone on Concurrent Anxiety and Insomnia Symptoms in Women With Postpartum Depression
Autor:
Kristina M. Deligiannidis, Leslie Citrome, Ming-Yi Huang, Sarah Acaster, Moshe Fridman, Vijayveer Bonthapally, Robert Lasser, Stephen J. Kanes
Publikováno v:
The Journal of Clinical Psychiatry. 84
Autor:
Alix Arnaud, Vijayveer Bonthapally
Publikováno v:
Journal of Affective Disorders. 301:445-447
Autor:
Ming-Yi Huang, Samantha Meltzer-Brody, Moshe Fridman, Sarah Acaster, Vijayveer Bonthapally, Stephen Kanes, Mark Kosinski, Margaret E. Gerbasi, Adi Eldar-Lissai, Paul Hodgkins
Publikováno v:
Current Medical Research and Opinion. 37:1221-1231
To evaluate the health-related quality of life (HRQoL) burden associated with postpartum depression (PPD), determine the extent to which clinical response impacts HRQoL, and estimate the impact of PPD and clinical response on healthcare resource util
Autor:
Moshe Fridman, Stephen Kanes, Margaret E. Gerbasi, Paul Hodgkins, Vijayveer Bonthapally, Sarah Acaster, Samantha Meltzer-Brody, Adi Eldar-Lissai
Publikováno v:
Journal of Women's Health. 30:385-392
Background: Brexanolone (BRX) injection was approved by the United States Food and Drug Administration in 2019 for the treatment of adults with postpartum depression (PPD) based on two Phase 3 clin...
Autor:
Samantha Meltzer-Brody, Paul Hodgkins, Vijayveer Bonthapally, Stephen Kanes, Moshe Fridman, Adi Eldar-Lissai, Sarah Acaster, Margaret E. Gerbasi
Publikováno v:
Archives of Women's Mental Health
The objective of this study is to explore the associations between the patient-reported Edinburgh Postnatal Depression Scale (EPDS) and Patient Health Questionnaire (PHQ)-9 and clinician-reported 17-item Hamilton Depression Rating Scale (HAMD-17) in
Autor:
Ellison Suthoff, Mark Kosinski, Alix Arnaud, Paul Hodgkins, Handan Gunduz-Bruce, Robert Lasser, Christopher Silber, Abdul J. Sankoh, Haihong Li, Brian Werneburg, Jeffrey Jonas, James Doherty, Stephen J. Kanes, Vijayveer Bonthapally
Publikováno v:
Journal of affective disorders. 308
Major depressive disorder (MDD), a disabling, potentially life-threatening condition, negatively affects health-related quality of life (HRQoL). This secondary analysis aimed to understand the impact of the neuroactive steroid zuranolone on HRQoL usi
Autor:
Margaret E, Gerbasi, Samantha, Meltzer-Brody, Sarah, Acaster, Moshe, Fridman, Vijayveer, Bonthapally, Paul, Hodgkins, Stephen J, Kanes, Adi, Eldar-Lissai
Publikováno v:
Journal of Women's Health
Background: Brexanolone (BRX) injection was approved by the United States Food and Drug Administration in 2019 for the treatment of adults with postpartum depression (PPD) based on two Phase 3 clinical trials. Materials and Methods: Data from the thr
Autor:
Vijayveer Bonthapally, E. Suthoff, Ken O'Day, Kellie Meyer, Paul Hodgkins, Brian Werneburg, Jeffrey Jonas, Alix Arnaud, Katie Stenson
Publikováno v:
Journal of affective disorders. 285
Background Zuranolone (SAGE-217) is a novel, investigational positive allosteric modulator of GABAA receptors being investigated in major depressive disorder (MDD). This analysis of phase 2 data quantified the benefit and risk of zuranolone (30mg) ve
Autor:
Moshe Fridman, Kristina M. Deligiannidis, Stephen J. Kanes, Sarah Acaster, Ming-Yi Huang, Ellison Suthoff, Vijayveer Bonthapally, Handan Gunduz-Bruce, Brian Werneburg, Robert Lasser
Publikováno v:
Biological Psychiatry. 89:S91